Regulus Therapeutics Inc (NASDAQ:RGLS)

1.16
Delayed Data
As of 4:00pm ET
 -0.04 / -3.33%
Today’s Change
0.79
Today|||52-Week Range
1.95
+11.54%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close1.20
Today’s open1.20
Day’s range1.14 - 1.24
Volume366,150
Average volume (3 months)620,654
Market cap$124.7M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-43.52%
Earnings growth (this year)+37.42%
Earnings growth (next 5 years)--
Revenue growth (last year)-94.25%
P/E ratioNM
Price/Sales99.52
Price/Book1.13

Competitors

 Today’s
change
Today’s
% change
GLMDGalmed Pharmaceutica...+0.18+3.34%
GTXIGTX Inc+1.10+7.10%
ZFGNZafgen Inc+0.25+3.22%
MEIPMEI Pharma Inc-0.01-0.46%
Data as of 4:00pm ET, 02/23/2018

Financials

Last reporting dateFebruary 23, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$1.2M
Annual profit (last year)-$81.8M
Net profit margin-6,853.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, COO &
Director
Joseph P. Hagan
Chief Financial &
Accounting Officer
Daniel R. Chevallard
Corporate headquarters
San Diego, California

Forecasts